Trials / Conditions / Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
5 registered clinical trials studyying Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients NCT01444417 | Amgen | Phase 3 |
| Completed | Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects NCT00515203 | Amgen | Phase 1 / Phase 2 |
| Completed | Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura NCT00415532 | Amgen | Phase 3 |
| Completed | Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura NCT00454857 | Amgen | — |
| Completed | Safety Study of AMG 531 in Japanese Subjects With ITP NCT00305435 | Kyowa Kirin Co., Ltd. | Phase 2 |